Absolute Pro LL. Peripheral Self-Expanding Stent System. Delivering Absolute Performance Extending Our Legacy FPO .035

Size: px
Start display at page:

Download "Absolute Pro LL. Peripheral Self-Expanding Stent System. Delivering Absolute Performance Extending Our Legacy FPO .035"

Transcription

1 Pro LL Peripheral Self-Expanding Stent System Clinically proven to treat long SFA lesions Superb durability 1- Delivering Performance Extending Our Legacy Uncompromised deliverability FPO.03 Endovascular Coitment Six Degrees does not recoend this

2 Pro LL Peripheral Self-Expanding Stent System Clinically Proven to Treat Long SFA Lesions 1-3 Lower binary restenosis rate and sustained clinical benefit with stent compared with Quality of life significantly improved after stenting compared to Superb Durability Excellent stent fracture resistance 1-4 Stent Design Resistance Surface Finish Stent Material - Stent material and stent design for outstanding flexibility and vessel conformability - Advanced stent electro and micro polish for optimal surface finish to enhance stent durability Uncompromised Deliverability Triaxial Technology Triaxial technology with: - Stabilizing sheath to absorb stored energy and minimize friction during deployment - I-Beam laser-cut hypotube for longitudinal strength, flexibility and pushability during stent delivery Ergonomic handle for easy one-handed, controlled deployment

3 Delivering Performance Triaxial Technology Stabilizing Sheath for deployment accuracy I-Beam for kink resistance and uncompromised deliverability Outer Member for ease of deployment Thumb Wheel for easy one-handed, controlled stent deployment

4 Extending Our Legacy Now available in 1 and lengths* 1 * Artwork shown not to scale. Stent optimal surface for enhanced stent durability Low Tip Profile for crossing tight lesions

5 Delivering Performance Binary Restenosis stent shows sustained benefit when compared to % % % % p=0.3 p=0.0 p=0.01 p= p=0.3 p=0.0 p=0.01 p= p=0.3 p=0.0 % % 1-3 Lowest fracture rate across trials 3 4.3% 13.% 4.% 3.%.2% 3.% 22.% 2.% +/-22.% Stent 13.% 24.2% p=0.031 p=0.013.% 4.3% 2.% +/Stent 4.3% 3.% 3.% 4.%.2% 4.% 3.% 22.% 2.% 13.% Stent Rate (per limb) DURABILITY I Study Follow-up 24 Follow-up 24 % DURABILITY 12 I Study DURABILITY I 12Study Registry 43 Registry 32 SIROCCO 24 II SIROCCO II % 242.2% % Follow-up % % % % % % Lesion length % 24 1.% Registry % 1.%.1% 1 1.% Protégé EverFlex.4 Lesion length Lesion length 1.2% 2.% 2.2% 2.% %.1% 12 1.% Wallstent 1.% 1 Protégé EverFlex.1%.4 1.% 12 Wallstent Protégé EverFlex.4 12 Wallstent % (gf) 0 0 (gf) 24 Pro LL LifeStent FlexStar XL Complete SE 24 Pro LL 24 LifeStent FlexStar XL Complete SE (gf) Pro LL LifeStent FlexStar XL Complete SE Data on file at Abbott Vascular. M. Schillinger et al. / NEJM; Vol 34, N1: 1-1 / M. Schillinger / Circulation 0; 11:24-24 S. Sabeti / J Endovasc Ther 0; 14: O. Schlager et al / J Endovasc Ther 0; 12:-4 S.H. Duda et al. J Endovasc Ther 0;13:01- Marc Bosiers et al. J Endovasc Ther 0; 1:21-2 SIROCCO II 00 Flexibility of Sheathed Stent on Delivery System Best-in-class flexibility during stent delivery

6 Pro LL Ordering Information LENGTH 0 (cm) Pro STOCK NUMBER CATHETER LENGTH 13 (cm) REFERENCE VESSEL SHEATH GUIDING CATHETER REFERENCE VESSEL SHEATH GUIDING CATHETER Ordering Information LENGTH 0 (cm) STOCK NUMBER CATHETER LENGTH (cm) Please contact your local representative for more information. Abbott Vascular Australia Abbot Vascular New Zealand Level, 1 Talavera Road North Ryde NSW 2113 Tel: 0 3 Tel: Fax: +1 2 Level 3, Kingdon Street New Market Auckland Tel: Tel: Fax: All illustrations included are artist s renditions. All tests performed by and data on file at Abbott Vascular. Pro is a trademark of Abbott Laboratories. self-expanding stent system is a trademark of Cordis, a J&J Company. LifeStent FlexStar XL Vascular Stent System is a trademark of C. R. Bard, Inc. Wallstent Endoprosthesis is a registered trademark of Boston Scientific Corp. Protégé EverFlex Self-Expanding Peripheral Stent System is a trademark of ev3 Inc. Complete SE Iliac is a trademark of Medtronic, Inc. This product is intended for use by or under the direction of a physician. Prior to use, it is important to read the package insert thoroughly for Instructions for Use, warnings and potential complications associated with use of this device. Information contained herein for distribution in Australia and New Zealand only. For more information, visit our web site at abbottvascular.com 0 Abbott Laboratories. All rights reserved. ANZ /12.

When Outcomes Matter, Design Matters

When Outcomes Matter, Design Matters to receive our latest news and key activities. Cordis S.M.A.R.T. Self-Expanding Nitinol Lower Extremity Solutions When Outcomes Matter, Design Matters For superficial femoral artery (SFA) and iliac lesions.

More information

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18 140 μm thin struts Clinically proven 4F low profile Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW Pulsar-18 Technical data / ordering info 140 μm thin struts - thinner than

More information

PERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System

PERFORMANCE YOU CAN TRUST. EverFlex Self-expanding Peripheral Stent with Entrust Delivery System PERFORMANCE YOU CAN TRUST EverFlex Self-expanding Peripheral Stent with Entrust Delivery System The Entrust Delivery System is designed to provide improved patient outcomes and procedural efficiency. The

More information

NIRxcell CoCr Coronary Stent System

NIRxcell CoCr Coronary Stent System cordis.com/nirxcell NIRxcell CoCr Coronary Stent System Exceptional Outcomes by Design Exceptionally low TLR rate of 5.1 % at 9 months 1 Superior Deliverability and Crossability 2 Best-in-class Conformability

More information

Mechanical Properties of the GORE TIGRIS Vascular Stent

Mechanical Properties of the GORE TIGRIS Vascular Stent Mechanical Properties of the GORE TIGRIS The nitinol frame makes it strong. The fluoropolymers make it flexible. Together, they make it unique. Purpose The association of target vessel restenosis with

More information

MEET M. Bosiers K. Deloose P. Peeters. SFA stenting in 2009 : The good and the ugly What factors influence patency?

MEET M. Bosiers K. Deloose P. Peeters. SFA stenting in 2009 : The good and the ugly What factors influence patency? MEET 2009 SFA stenting in 2009 : The good and the ugly What factors influence patency? M. Bosiers K. Deloose P. Peeters 1 TASC II 2007 vs TASC 2000 Type A Type B Type C Type D 2000 < 3 cm 3-5 cm < 3 cm

More information

Finally, the Control You Need to Deliver Accurate Treatment

Finally, the Control You Need to Deliver Accurate Treatment Finally, the Control You Need to Deliver Accurate Treatment LIFESTREAM Covered Stent. has joined BD When you reach for a balloon expandable stent, you require accuracy. The LIFESTREAM Balloon Expandable

More information

Chronic Total Occlusion (CTO) Technologies

Chronic Total Occlusion (CTO) Technologies to receive our latest news and key activities. Chronic Total Occlusion (CTO) Technologies Re-open vital channels LinkedIn page Follow us on CORDIS EMEA OUTBACK LTD Re-Entry Catheter True Lumen Re-Entry

More information

Or is the ivolution stent a better alternative? EVOLUTION 12-month data

Or is the ivolution stent a better alternative? EVOLUTION 12-month data Or is the ivolution stent a better alternative? EVOLUTION 12-month data Dr. Marc Bosiers LINC 2018, Leipzig Conflict of interest have the following potential conflicts of interest to report: Consulting

More information

Update in femoral angioplasty & stenting PRO

Update in femoral angioplasty & stenting PRO MEET 2008 Update in femoral angioplasty & stenting Will extra-long stents be a solution for SFA disease? PRO Patrick Peeters, MD Chief department Cardiovascular & Thoracic Surgery, Imelda Hospital, Bonheiden,

More information

5F Devices with 0.035

5F Devices with 0.035 Ambulatory mamagement for PAD endovascular treatment 5F Devices with 0.035 Flavio Airoldi, MD Multmedica IRCCS Milan - ITALY flavio.airoldi@multimedica.it Is there a need for low profile delivery systems?

More information

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

Expanding to every demand: The GORE VIABAHN VBX Stent Graft Expanding to every demand: The GORE VIABAHN VBX Stent Graft GORE, VIABAHN, and designs are trademarks of W. L. Gore & Associates. 2017 W. L. Gore & Associates, Inc. Program Faculty Martin Austermann, MD

More information

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide 2-Year Results Of The Tack Optimized Balloon Angioplasty (TOBA) Trial For Fem- Pop Lesions Demonstrates Safety and Efficacy Of The Tack Endovascular System In Repairing Focal Post-PTA Dissections Christian

More information

LOWERING THE PROFILE RAISING THE BAR

LOWERING THE PROFILE RAISING THE BAR LOWERING THE PROFILE RAISING THE BAR INNOVATIVE LOW PROFILE. ADVANCED CLINICAL PERFORMANCE. The AFX TM Endovascular AAA System integrates anatomical fixation with an advanced delivery system and graft

More information

Talent Abdominal Stent Graft

Talent Abdominal Stent Graft Talent Abdominal with THE Xcelerant Hydro Delivery System Expanding the Indications for EVAR Treat More Patients Short Necks The Talent Abdominal is the only FDA-approved device for proximal aortic neck

More information

Chronic Total Occlusion (CTO) Technologies. Re-open vital channels

Chronic Total Occlusion (CTO) Technologies. Re-open vital channels Chronic Total Occlusion (CTO) Technologies Re-open vital channels OUTBACK LTD Re-Entry Catheter True Lumen Re-Entry Technology Get back into the true lumen with ease and precision There are a number of

More information

Minimizing Burden, the effect of thin strut and low Chronic Outward Force SE stents

Minimizing Burden, the effect of thin strut and low Chronic Outward Force SE stents Minimizing Burden, the effect of thin strut and low Chronic Outward Force SE stents Prof. Yong LIU The affiliated hospital of southwest medical university LINC AP 2018, Hong Kong 13-15 th March Disclosure

More information

All-In-One. Iliac Branch System. PER F ORM ANC E b y d e s i g n ILIAC BRANCH ENDOPROSTHESIS

All-In-One. Iliac Branch System. PER F ORM ANC E b y d e s i g n ILIAC BRANCH ENDOPROSTHESIS All-In-One Iliac Branch System PER F ORM ANC E b y d e s i g n ILIAC BRANCH ENDOPROSTHESIS Exclusively Designed for Use in The GORE EXCLUDER Iliac Branch designed for the iliac branch, built from the same

More information

Update on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany

Update on the Levant 2 Clinical Trial Programme. Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Update on the Levant 2 Clinical Trial Programme Dierk Scheinert, MD University Hospital Leipzig Leipzig, Germany Disclosure Speaker name: Dierk Scheinert I have the following potential conflicts of interest

More information

THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT

THE THE MORE MORE NATURAL APPROACH TO OPTIMAL FIT THE THE MORE MORE NATURAL APPROACH Natural Approach TO Optimal Fit TO OPTIMAL FIT Conformability without Compromise THE STANDARD IN Conformability AND Designed for flexibility and conformability in tortuous

More information

Proven Performance Through Innovative Design *

Proven Performance Through Innovative Design * Proven Performance Through Innovative Design * Deliver Our Next Generation AV Covered Stent Results The COVERA Vascular Covered Stent builds upon proven technologies from the category leader in AV Access.

More information

FROM THE EVERYDAY TO THE EXTRAORDINARY

FROM THE EVERYDAY TO THE EXTRAORDINARY FROM THE EVERYDAY TO THE EXTRAORDINARY Created with the collaboration of more than 250 physicians around the world, ENDURANT empowers you to create stronger outcomes for more patients, including those

More information

SFA lesion treatment: China experience. Wei Liang, MD

SFA lesion treatment: China experience. Wei Liang, MD SFA lesion treatment: China experience Wei Liang, MD Disclosure I do not have any potential conflict of interest Background PAD: 14% - 20% in adults Aorta & Iliac A: 30% Femoral & Pop A: 80-90% Tibial

More information

Sustained Release. Superior Results.

Sustained Release. Superior Results. ELUVIA Drug-Eluting Vascular Stent System Sustained Release. Superior Results. Superiority determined in Post Hoc Superiority Analysis. 12-Month Primary Patency rate of 86.8% in the Eluvia arm (n=309)

More information

The Final Triumph Of Endovascular Therapy In SFA Treatment

The Final Triumph Of Endovascular Therapy In SFA Treatment The Final Triumph Of Endovascular Therapy In SFA Treatment MEET 07 Mark W. Mewissen, M.D. Director, St Lukes Vascular Center Milwaukee, WI Endovascular Therapy In SFA Treatment: Works In Progress! Mark

More information

INTRODUCING. Cordis POWERFLEX Pro PTA Dilatation Catheter

INTRODUCING. Cordis POWERFLEX Pro PTA Dilatation Catheter We Are Helping You Save Patients Limbs by Expanding the Portfolio INTRODUCING Cordis POWERFLEX Pro 0.035 PTA Dilatation Catheter Advanced Crossing Ability. Remarkable Versatility. Cordis POWERFLEX Pro

More information

EluNIR. Ridaforolimus Eluting Coronary Stent System. Advancing Deliverability for the Road Ahead

EluNIR. Ridaforolimus Eluting Coronary Stent System. Advancing Deliverability for the Road Ahead Ridaforolimus Eluting Coronary Stent System Advancing Deliverability for the Road Ahead The Coronary Stent System Raising the Bar on Drug-Eluting Stent Technology Introducing the Coronary Stent System,

More information

Shaping the future with the swirling flow stent

Shaping the future with the swirling flow stent NEW SIZES AVAILABLE the swirling flow THE SWIRLING FLOW STENT Significantly better performance than straight control s* in a randomised fempop study ¹ GET WITH THE FLOW the swirling flow IMPROVED BIOMECHANICAL

More information

A Data-driven Therapeutic Algorithm For Choosing Among Currently Available Tools For SFA Intervention

A Data-driven Therapeutic Algorithm For Choosing Among Currently Available Tools For SFA Intervention A Data-driven Therapeutic Algorithm For Choosing Among Currently Available Tools For SFA Intervention William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia

More information

Durable outcomes. Proven performance.

Durable outcomes. Proven performance. Durable outcomes. Proven performance. GORE EXCLUDER AAA Endoprosthesis GORE EXCLUDER Iliac Branch Endoprosthesis GORE EXCLUDER AAA Endoprosthesis The most-studied* EVAR stent graft designed for durable

More information

Right Choice for Right Angles

Right Choice for Right Angles Right Choice for Right Angles The Anatomy of Technology Aorfix gives you technology that conforms to patient anatomy, optimising both procedure and post-operative performance. Fishmouth for optimum neck

More information

INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY. VascuFlex Peripheral Stent Systems. Self-Expanding Peripheral Nitinol Stents

INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY. VascuFlex Peripheral Stent Systems. Self-Expanding Peripheral Nitinol Stents INTERVENTIONAL VASCULAR DIAGNOSTICS AND THERAPY VascuFlex Peripheral Stent Systems Self-Expanding Peripheral Nitinol Stents VascuFlex Multi-LOC MULTIPLE STENT DELIVERY SYSTEM (MSDS) Biomechanical challenges

More information

Advanced Innovation for Exceptional Performance

Advanced Innovation for Exceptional Performance Advanced Innovation for Exceptional Performance longest BALLOON LENGTHS ON THE MARKET Bard Peripheral Vascular Ultraverse 014 300 mm Boston Scientific Coyote 220 mm Cordis SLEEK RX 220 mm Aviator Plus

More information

Is a Stent or Scaffold Necessary in The SFA?

Is a Stent or Scaffold Necessary in The SFA? 1 2 3 Is a Stent or Scaffold Necessary in The SFA? Stents were developed to optimize acute results after angioplasty Specifically, stents are universally accepted to manage flow limiting dissections and

More information

CHALLENGES IN FEMORO-POPLITEAL STENTING

CHALLENGES IN FEMORO-POPLITEAL STENTING CHALLENGES IN FEMORO-POPLITEAL STENTING Karathanos C MD, MSc, PhD, Athanasoulas A, Rousas N, Spanos K, Giannoukas A Department of Vascular Surgery, University Hospital of Larissa, Faculty of Medicine,

More information

The evolution. AORFIX AAA Stent Graft now with the new AORFLEX Delivery System

The evolution. AORFIX AAA Stent Graft now with the new AORFLEX Delivery System The evolution of AORFIX AORFIX AAA Stent Graft now with the new AORFLEX Delivery System The confident choice for the right angles AORFIX the only AAA stent graft approved for all angulations from 0 90,

More information

A New EVAR Device for Infrarenal AAAs

A New EVAR Device for Infrarenal AAAs A New EVAR Device for Infrarenal AAAs Peter Nelson, MD, MS Assistant Professor of Surgery MM0203 Rev. 01 Current U.S. EVAR Devices Anatomical Fixation Proximal Fixation Powerlink - Endologix Excluder WL

More information

NC EMERGE TM PTCA Dilatation Catheter

NC EMERGE TM PTCA Dilatation Catheter LEARN MORE Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device. Information for use only in countries with applicable health

More information

ABDOMINAL XT ABDOMINAL STENT GRAFT SYSTEM

ABDOMINAL XT ABDOMINAL STENT GRAFT SYSTEM ABDOMINAL XT ABDOMINAL STENT GRAFT SYSTEM Pure performance and quality: Stent graft systems by JOTEC JOTEC is an innovation-oriented company with consistent focus on its core competencies: the development

More information

Expect Slimline (SL) Endoscopic Ultrasound Aspiration Needle EXPANDED INDICATIONS AVAILABLE IN THE U.S. WITH

Expect Slimline (SL) Endoscopic Ultrasound Aspiration Needle EXPANDED INDICATIONS AVAILABLE IN THE U.S. WITH Expect Slimline (SL) Endoscopic Ultrasound Aspiration Needle AVAILABLE IN THE U.S. WITH EXPANDED INDICATIONS Expect Slimline (SL) Endoscopic Ultrasound Aspiration Needle Expect Slimline (SL) Endoscopic

More information

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA

Disclosures. In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA In the DCB Era, How Do I Choose To Use a Stent? When to Stent and What Devices to Use in the SFA Disclosures No financial disclosures. Cameron M. Akbari, MD, MBA, FACS Site Director, Vascular Surgery Medstar

More information

Recent Advances in Peripheral Salvage

Recent Advances in Peripheral Salvage Recent Advances in Peripheral Salvage Dr Shaiful Azmi Yahaya, MD, MMed, FNHAM, FAsCC, FAPSIC Consultant Cardiologist and Peripheral Interventionist, Institut Jantung Negara Disclosure I am proctoring for

More information

Could a combination of DCB + stent be the answer in complex SFA lesions

Could a combination of DCB + stent be the answer in complex SFA lesions Could a combination of DCB + stent be the answer in complex SFA lesions Sven Bräunlich, MD Division of Interventional Angiology University-Hospital Leipzig, Germany Disclosure Speaker name: Sven Bräunlich

More information

Does stent design influence the results of SFA stenting?

Does stent design influence the results of SFA stenting? LINC 2015, Leipzig A.Z. Sint-Blasius, Dendermonde Marc Bosiers Koen Deloose Joren Callaert Imelda Hospital, Bonheiden Patrick Peeters Jürgen Verbist OLV Hospital, Aalst Does stent design influence the

More information

JETSTREAM Atherectomy System DELIVERING VERSATILITY TO RESTORE FLOW

JETSTREAM Atherectomy System DELIVERING VERSATILITY TO RESTORE FLOW JETSTREAM Atherectomy System DELIVERING VERSATILITY TO RESTORE FLOW DISCOVER THE VALUE OF VERSATILITY Versatility means not having to guess the morphology! Peripheral arterial lesions can present with

More information

Complex ilio-caval revascularization in chronic venous obstruction with the Venovo Stent. Michael K. W. Lichtenberg MD, FESC

Complex ilio-caval revascularization in chronic venous obstruction with the Venovo Stent. Michael K. W. Lichtenberg MD, FESC Complex ilio-caval revascularization in chronic venous obstruction with the Venovo Stent Michael K. W. Lichtenberg MD, FESC German Venous Center Arnsberg, Germany Not available for sale or distribution

More information

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA Brian DeRubertis, MD, FACS Associate Professor of Surgery UCLA Division

More information

XIENCE Sierra INTRODUCING

XIENCE Sierra INTRODUCING INTRODUCING Sierra With the safety you ve always relied on and the deliverability you ve always wanted, choosing the right stent is now an easier decision. START 2017 Abbott. All rights reserved. AP2944678-OUS

More information

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster

Roadsaver the paradigm shift in carotid artery treatment. G. Torsello Münster Roadsaver the paradigm shift in carotid artery treatment G. Torsello Münster Disclosure Speaker name:...g. Torsello... I have the following potential conflicts of interest to report: Consulting Employment

More information

My personal experience with INCRAFT in standard and challenging cases

My personal experience with INCRAFT in standard and challenging cases My personal experience with INCRAFT in standard and challenging cases G Pratesi, MD Vascular Surgery University of Rome Tor Vergata giovanni.pratesi@uniroma2.it Disclosure Speaker name: Giovanni Pratesi,

More information

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES

MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES MAXIMIZE RADIAL SOLUTIONS TO PERIPHERAL CHALLENGES PUSHING BOUNDARIES Terumo Interventional Systems is committed to your success with innovative procedural solutions and ongoing support for your most challenging

More information

On behalf of the DURABILITY Investigators:

On behalf of the DURABILITY Investigators: On behalf of the DURABILITY Investigators: S. Müller-Hülsbeck 1, M. Bosiers 2, G. Torsello 3, D. Scheinert 4, H. Gissler 5, J. Ruef 6, T. Jahnke 7, P. Peeters 8, K. Daenens 9, J. Lammer 1 1 Ev.-Luth. Diakonissenanstalt

More information

thoracic stent graft system Smallest delivery profile as from 20 F

thoracic stent graft system Smallest delivery profile as from 20 F thoracic stent graft system Smallest delivery profile as from 20 F Third-generation thoracic stent graft system effective, precise and safe JOTEC develops stent graft systems in close collaboration with

More information

Indications for use. Contraindications within the United States

Indications for use. Contraindications within the United States Indications for use Indications within the United States The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta, including: Isolated lesions

More information

Vascular V12. Covered Stent. The New Standard of Care

Vascular V12. Covered Stent. The New Standard of Care Vascular V12 Covered Stent The New Standard of Care Innovation Novel Thermo-Conformable Covered Stent 316L stainless steel stent completely encapsulated in a proprietary one piece eptfe film cast covering

More information

Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM

Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM Assurant Cobalt Iliac BALLOON EXPANDABLE STENT SYSTEM Innovating for life. CONFORMABILIT Y 6 F S H E AT H C O M PAT I B I L I T Y THE ASSURANT COBALT ILIAC STENT, WITH ITS UNIQUE COBALT CHROMIUM MODULAR

More information

TurboHawk. Plaque Excision System

TurboHawk. Plaque Excision System TurboHawk Plaque Excision System Twelve-month Patency in Diabetics DIABETICS VS. NON-DIABETICS 12-month Primary Patency (%) Diabetic patients show a more positive response to directional atherectomy than

More information

Access More Patients. Customize Each Seal.

Access More Patients. Customize Each Seal. Access More. Customize Each Seal. The Least Invasive Path Towards Proven Patency ULTRA LOW PROFILE TO EASE ADVANCEMENT The flexible, ultra-low 12F ID Ovation ix delivery system enables you to navigate

More information

SEE WHY ZILVER PTX IS A GAME CHANGER.

SEE WHY ZILVER PTX IS A GAME CHANGER. SEE WHY ZILVER PTX IS A GAME CHANGER. SIMPLE DEPLOYMENT cookmedical.eu Game-changing design Game-changing evidence Game-changing drug effect Zilver PTX D RUG-ELUTING PERIPHERAL STENT This is how the Zilver

More information

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii SCAFFOLD Study Gore PTFE mesh-covered stent preclinical and clinical data so far Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii Disclosure Peter A. Schneider... I have the following

More information

CLOSES WITH SECURITY. LEAVES WITHOUT A TRACE.

CLOSES WITH SECURITY. LEAVES WITHOUT A TRACE. CLOSES WITH SECURITY. LEAVES WITHOUT A TRACE. Close with Confidence. Leave Nothing Behind. The innovative design and predictable deployment of MYNX CONTROL Vascular Closure Device (VCD) delivers outstanding

More information

Zenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up

Zenith Renu AAA Converter Graft. Device Description Planning and Sizing Deployment Sequence Patient Follow-Up Zenith Renu AAA Converter Graft Device Description Planning and Sizing Deployment Sequence Patient Follow-Up Device description: Device indications The Zenith Renu AAA Converter Graft with Z-Trak Introduction

More information

Clinical benefits on DES Patient s perspectives

Clinical benefits on DES Patient s perspectives Clinical benefits on DES Patient s perspectives Dr. Skyi Pang Vascular Surgeon Department of Surgery Pamela Youde Nethersole Eastern Hospital Hong Kong Disclosure Speaker name: Skyi Pang... I have the

More information

The Art of. Flow Restoration. Ikazuchi Zero. Semi-Compliant PTCA Balloon OVERVIEW CROSSABILITY LOW PROFILE CASE STUDY CODES

The Art of. Flow Restoration. Ikazuchi Zero. Semi-Compliant PTCA Balloon OVERVIEW CROSSABILITY LOW PROFILE CASE STUDY CODES The Art of Flow Restoration Japan s Recognized PCI Technology For Both Everyday and Complex CTO Cases* Manufactured by Kaneka Corporation, one of Japan s leading providers of interventional devices. Now

More information

Evaluating the economic value of 5F systems for outpatients

Evaluating the economic value of 5F systems for outpatients Evaluating the economic value of 5F systems for outpatients Pr Yann Gouëffic, MD, PhD Department of vascular surgery - University Hospital of Nantes, France Disclosure Speaker's name: Yann Goueffic I have

More information

Appropriate Device Selection for Endovascular Procedures

Appropriate Device Selection for Endovascular Procedures Appropriate Device Selection for Endovascular Procedures Thomas M. Shimshak, MD Florida Hospital Heartland Medical Center Sebring, Florida Disclosures Speaker s Bureau: Abbott Vascular Boston Scientific

More information

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit?

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit? Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit? John R. Laird Adventist Heart and Vascular Institute St. Helena, CA Disclosure Speaker name: John R. Laird... I have

More information

ENDOVASCULAR FEMORAL STENTS CAN WE RELY ON LONG-TERM FRIENDSHIP?

ENDOVASCULAR FEMORAL STENTS CAN WE RELY ON LONG-TERM FRIENDSHIP? ENDOVASCULAR FEMORAL STENTS CAN WE RELY ON LONG-TERM FRIENDSHIP? MEET 2007 MULTIDISCIPLINARY EUROPEAN ENDOVASCULAR THERAPY COURSE CANNES Emad A Hussein ; MD Vascular Surgery Department Ain Shams University

More information

Treatment Strategies for Long Lesions of greater than 20 cm

Treatment Strategies for Long Lesions of greater than 20 cm Treatment Strategies for Long Lesions of greater than 20 cm Donald L. Jacobs, MD C. Rollins Hanlon Professor and Chair Chair of the Department of Surgery Saint Louis University Disclosure Speaker name:

More information

4/14/2016. Faculty Disclosure. Drug-eluting technology in the SFA and Popliteal. Typical SFA Disease Pattern. Why Peripheral Artery Disease Matters

4/14/2016. Faculty Disclosure. Drug-eluting technology in the SFA and Popliteal. Typical SFA Disease Pattern. Why Peripheral Artery Disease Matters Drug-eluting technology in the SFA and Popliteal David Paul Slovut, MD, PhD Associate Professor of Medicine and Surgery Co-director of TAVR program Director of Advanced Intervention Faculty Disclosure

More information

Straub Endovascular System &

Straub Endovascular System & Straub Endovascular System & S t r a u b E n d o v a s c u l a r To o l s Straub Endovascular System Effective debulking in occluded arteries and veins Effective debulking in many indications Rotarex

More information

Durability of The Endurant Stent-Graft through 5 Years

Durability of The Endurant Stent-Graft through 5 Years Durability of The Endurant Stent-Graft through 5 Years Michel S. Makaroun MD Co-Director, UPMC Heart and Vascular Institute Professor and Chair, Division of Vascular Surgery University of Pittsburgh School

More information

Pulsar stent technology

Pulsar stent technology Pulsar stent technology Michael K. W. Lichtenberg Vascular Center Arnsberg Disclosures Speaker name: Michael Lichtenberg... I have the following potential conflicts of interest to report: X Consulting

More information

Superficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA

Superficial Femoral Artery Intervention: The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA : The gift that keeps on giving! Wm. Britton Eaves,MD WKHSC Bossier City, LA Peripheral arterial disease (PAD) of the superficial femoral artery (SFA) is the most common cause of intermittent claudication

More information

Ovation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic

Ovation. Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Ovation Sean Lyden, MD Department Chair, Vascular Surgery Cleveland Clinic Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement

More information

DURABLE. CONSISTENT. SAFE. IN.PACT Admiral Drug-Coated Balloon

DURABLE. CONSISTENT. SAFE. IN.PACT Admiral Drug-Coated Balloon DURABLE. CONSISTENT. SAFE. Drug-Coated Balloon THE SCIENCE BEHIND THE OUTCOMES DCB has proven, long-term durable outcomes across multiple clinical trials, as well as across complex patient and lesion types.

More information

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu

When and how to use distal protection devices for lower extremity revascularization. Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu When and how to use distal protection devices for lower extremity revascularization Peter A. Schneider, MD Kaiser Foundation Hospital, Honolulu Disclosure Peter A. Schneider Potential conflicts of interest

More information

Yukon Choice PC Translumina trust is what counts

Yukon Choice PC Translumina trust is what counts Sirolimus Eluting Coronary Stent System 5-Years Randomized Clinical Follow-Up Translumina trust is what counts trust is what counts DES with excellent long-term clinical outcome The Translumina PC drug-eluting

More information

Ruby Coil. Large Volume Detachable Coils

Ruby Coil. Large Volume Detachable Coils Ruby Coil Ruby Case Examples 38 mm Hepatic Artery Aneurysm Pulmonary AVM 2 Coils Dr. James Benenati Miami Cardiac and Vascular Institute, FL Y90 Embolization Type 2 Endoleak Dr. J Moskovitz Florida Hospital,

More information

The Challenge of Accurately Stenting Aorto-Ostial Lesions

The Challenge of Accurately Stenting Aorto-Ostial Lesions The Challenge of Accurately Stenting Aorto-Ostial Lesions In a retrospective study of 100 patients in whom stents were placed using angiographic landmarks, correct stent positioning was achieved in only

More information

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD Faculty Disclosure Thomas Zeller, MD For the 12 months preceding this presentation, I disclose the following types of

More information

A Dedicated Venous Self-expanding Oblique Hybrid Nitinol Stent (Sinus-Obliquus Stent)

A Dedicated Venous Self-expanding Oblique Hybrid Nitinol Stent (Sinus-Obliquus Stent) A Dedicated Venous Self-expanding Oblique Hybrid Nitinol Stent (Sinus-Obliquus Stent) Anna Stuck, Rolf P. Engelberger, Nils Kucher Division of Angiology Cantonal Hospital Fribourg & Bern University Hospital

More information

Resolute Integrity. Independent Conformability Assessment

Resolute Integrity. Independent Conformability Assessment Resolute Integrity Independent Conformability Assessment Stent Conformability and its Clinical Importance Immediate post-deployment stent geometry determines neointimal thickness independently of arterial

More information

Long-term results with interwoven nitinol stents vs. BMS vs. DCB

Long-term results with interwoven nitinol stents vs. BMS vs. DCB Long-term results with interwoven nitinol stents vs. BMS vs. DCB Dierk Scheinert, MD Division of Interventional Angiology University Hospital Leipzig, Germany Disclosure Advisory Board /Consultant: Abbott,

More information

System.

System. System www.penumbrainc.com POD System Case Examples 45 cm of POD Packing Coil in 1.5 to 3 mm diameter dilating vessel Bronchial Artery Embolization Dr. Amit Kakkar and Dr. Aksim Rivera, Bronx, NY Inflow:

More information

Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography

Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography Jon C. George, MD; Vincent Varghese, DO From the Deborah Heart and Lung Center, Browns Mills, New Jersey. ABSTRACT:

More information

Maximize Control. Minimize Migration.

Maximize Control. Minimize Migration. Maximize Control. Minimize Migration. New SHORT WIRE Delivery System SHORT W IRE BILIARY ENDOPROSTHESIS Improved treatment of biliary strictures The self-expanding, fully covered metal stent is intended

More information

PressureWire Aeris with Agile Tip Technology. Wireless FFR Functionality and Handles like a Workhorse PCI Guidewire 1

PressureWire Aeris with Agile Tip Technology. Wireless FFR Functionality and Handles like a Workhorse PCI Guidewire 1 Home» Products» All International Products» PressureWire Aeris with Agile Tip Technology PressureWire Aeris with Agile Tip Technology This device is commercially available for use in select international

More information

New Fully Absorbable Patch Based Large Hole Vascular Closure Device

New Fully Absorbable Patch Based Large Hole Vascular Closure Device New Fully Absorbable Patch Based Large Hole Vascular Closure Device Jeffrey J. Popma, MD Beth Israel Deaconess Medical Center, Boston, MA Disclosure Statement of Financial Interest Over the past year,

More information

Filtek. Bulk Fill. Posterior Restorative. One. and done.

Filtek. Bulk Fill. Posterior Restorative. One. and done. Filtek Bulk Fill Posterior Restorative One and done. Introducing Fast and easy One increment up to 5 mm. Excellent handling and sculptability. No expensive dispensing devices or time-consuming layers.

More information

Challenging anatomies demand versatility.

Challenging anatomies demand versatility. Challenging anatomies demand versatility. The Distinct Advantages of Separating Seal and Fixation ANATOMICAL FIXATION Unlike proximal fixation designs, the AFX bifurcated unibody endograft allows for natural

More information

Root ZX mini Proven Accuracy in a New Compact Design. Thinking ahead. Focused on life.

Root ZX mini Proven Accuracy in a New Compact Design. Thinking ahead. Focused on life. Root ZX mini Proven Accuracy in a New Compact Design Thinking ahead. Focused on life. Root ZX mini is compact, lightweight, and portable. It can be placed on the tray or any other convenient place. Convenient

More information

Maximizing Outcomes in a complex population with Drug-coated balloon

Maximizing Outcomes in a complex population with Drug-coated balloon Maximizing Outcomes in a complex population with Drug-coated balloon March 13, 2018 Chumpol Wongwanit, MD Siriraj Hospital, Mahidol University, Bangkok, Thailand LINC Asia-Pacific 2018, Hong Kong Disclosure

More information

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Carotid Technologies and Protection Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL Disclosure Statement

More information

- Saturday, February 03, :56:12 PM - IP Address:

- Saturday, February 03, :56:12 PM - IP Address: 446 Original communication Multiple stent delivery system Multi-LOC, a new technology for spot-stenting of the femoropopliteal artery proof of concept study in a preclinical large animal model Martin Sigl

More information

Cordis ExoSeal. Maximise Clinical Safety*. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD

Cordis ExoSeal. Maximise Clinical Safety*. The novel approach to secure and easy closure. Vascular Closure Device CORDIS EXOSEAL VCD Cordis ExoSeal Vascular Closure Device CORDIS EXOSEAL VCD Maximise Clinical Safety*. The novel approach to secure and easy closure. * Clinical data from the ECLIPSE Trial indicates safety in terms of vascular

More information

FLEXIBLE, BALOON EXPANDABLE

FLEXIBLE, BALOON EXPANDABLE EARLY RESULTS OF A CLINICAL TRIAL OF FLEXIBLE, BALOON EXPANDABLE COVERED STENT GRAFT IN ILIAC OCCLUSIVE DISEASE Chris LeCroy Coastal Vascular and Interventional Pensacola, Florida Clinical Trial WL GORE

More information

A CATHETER FAMILY FOR ALL YOUR PATIENT NEEDS

A CATHETER FAMILY FOR ALL YOUR PATIENT NEEDS A CATHETER FAMILY FOR ALL YOUR PATIENT NEEDS MAHURKAR * Elite acute dialysis catheter family EFFICIENCY OF DIALYSIS IN REVERSE FLOW Less than one percent recirculation Symmetrical tip design minimizes

More information

Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment

Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Challenges with Complex Anatomies Advancing Care in Endovascular Aortic Treatment Robert Y. Rhee, MD Chief, Vascular and Endovascular Surgery Director, Aortic Center Maimonides Medical Center Brooklyn,

More information

CAROTID ARTERY ANGIOPLASTY

CAROTID ARTERY ANGIOPLASTY CAROTID ARTERY ANGIOPLASTY Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline

More information